Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?
Juan Eduardo Megías‐Vericat, Octavio Ballesta‐López, Eva Barragán, David Martínez‐Cuadrón, Pau Montesinos
Topics & Concepts
Myeloid leukemiaTyrosine kinaseMedicineTyrosine-kinase inhibitorClinical trialCancer researchTargeted therapyLeukemiaOncologyImmunologyInternal medicineCancerReceptorAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and Treatment